Medical/Pharmaceuticals

KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to Manufacture Generic Product for Filing in Japan

TAIPEI, Aug. 5, 2021 /PRNewswire/ -- KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has contracted with Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals for the manufacturing of generic product for filing inJapan. KYOWA will be...

2021-08-05 14:50 1851

Inmagene and Kissei Enter into an Exclusive License Agreement for Fostamatinib in China

SHANGHAI and SAN DIEGO and NAGANO, Japan, Aug. 5, 2021 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") and Kissei Pharmaceutical Co., Ltd. ("Kissei") announced today that they have entered into an exclusive license agreement for the development and commercialization of fostamatinib in ma...

2021-08-05 14:00 1891

Everest Medicines Announces Approval of Clinical Trial Application by China NMPA for Phase 3 Trial of Xerava(TM) for Community-Acquired Bacterial Pneumonia

SHANGHAI, Aug. 5, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater Ch...

2021-08-05 13:12 3667

Chinese Multinational Technology Company, HUAWEI, Aligns With Singapore-Based Healthtech Start-up PLANO to Tackle the Global Problem of Myopia

SINGAPORE, Aug. 5, 2021 /PRNewswire/ -- Shenzhen, Guangdong, China, and Singapore – Huawei Technologies Co. Ltd. (hereinafter, Huawei) and Plano Pte. Ltd. (hereinafter, Plano) today announced their partnership to address the global problem of myopia. Through this partnership, Huawei and Plano wil...

2021-08-05 10:00 1832

Over 3,000 units of HFNC delivered to Poland and Peru, Micomme Medical helps the world fight against COVID-19 pandemic

CHANGSHA, China, Aug. 5, 2021 /PRNewswire/ -- Recently, Micomme has associated with Polish and Peruvian partners to accomplish the government centralized purchase of 1,600 and 1,500 units of HFNC respectively. Both purchases are strategic material reserves of the local governments. The global pa...

2021-08-05 09:55 1818

A New Approach to Dealing With Shortsightedness (Myopia) & Dry Eye in Children

PETALING JAYA, Malaysia  , Aug. 5, 2021 /PRNewswire/ -- VISTA Eye Specialist (VISTA) is one of the first among eyecare professionals inMalaysia to adopt an all-in-one diagnostic tool - the MYAH by Topcon, that offers the essential tools for shortsightedness (myopia) management and also as an evol...

2021-08-05 08:00 4310

Wealth Dynamix Wins 'XCelent Functionality Award' in New Wealth Management CRM Report

LONDON, Aug. 5, 2021 /PRNewswire/ -- Wealth Dynamix , a global leader in Client Lifecycle Management (CLM) solutions, today announced its selection by global research and advisory firm Celent as a winner of the XCelent Functionality Award. The award was revealed i...

2021-08-05 06:58 2358

ABL Bio Receives IND Approval for Phase 1 Clinical Trial of ABL501, an anti-LAG-3/PD-L1 Bispecific Antibody

* South Korea's MFDS clears IND application for a Phase 1 study evaluating the safety and preliminary efficacy of ABL501 as a monotherapy for solid tumor treatment * ABL's third IND this year for bispecific antibody therapeutics SEONGNAM, South Korea, Aug. 4, 2021 /PRNewswire/ -- ABL Bio, Inc...

2021-08-04 21:30 1338

Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine

GAITHERSBURG, Md., Aug. 4, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has reached an agreement with the European Commission (EC) for the purchase of up to 200 million doses...

2021-08-04 21:10 8633

Alterity Therapeutics Announces New US Patent to Expand its Portfolio of Compounds for Neurodegenerative Diseases including Alzheimer's and Parkinson's

MELBOURNE, Australia, Aug. 4, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced the United States Patent and Trademark Of...

2021-08-04 20:39 24615

New Global Study Reveals Post-Pandemic Consumer Behaviours, Expectations and Concerns

Enduring appeal of in-store shopping, and continued fears about data privacy among surprising findings in "Future of Commerce |The Why Behind the Buy" LONDON, Aug. 4, 2021 /PRNewswire/ -- As the marketing industry worldwide continues its efforts to both map and navigate the post-pandemic commerce...

2021-08-04 19:00 1233

MitraClip implant at Apollo Hospitals saves 41-year-old farmer who waited 91 days for heart transplant

"1 out of 5 patients may get off the heart transplant list if they have access to this therapy" - says Dr. Sai Satish CHENNAI, India, Aug. 4, 2021 /PRNewswire/ -- Apollo Hospitals, Asia's foremost and most trusted healthcare group, today announced a successful MitraClip implant on a 41-year-old ...

2021-08-04 18:50 1953

Insilico Medicine Announces the Preclinical Candidate for Kidney Fibrosis Discovered Using End-to-End Artificial Intelligence Engine

HONG KONG, Aug. 4, 2021 /PRNewswire/ -- Insilico Medicine, a global company specializing in the applications of the next-generation machine learning technologies for drug discovery and development, announced today that its AI-powered drug discovery platform had delivered the preclinical candidate...

2021-08-04 18:11 1939

Columbia Clinic signed a cooperation agreement with Boehringer Ingelheim

SHANGHAI, Aug. 4, 2021 /PRNewswire/ -- On August 3rd, 2021, Columbia China, signed a cooperation agreement with Consanas Rehabilitation, brand of Boehringer Ingelheim. The agreement will allow both parties to complement each other's medical resources and to carry out in-depth collaboration on tal...

2021-08-04 16:19 1256

Clarivate Acquires Bioinfogate, Reinforcing Position as Premier Provider of End-to-End Research Intelligence Solutions for Life Sciences

LONDON, Aug. 4, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it has acquired Bioinfogate, a leading provider of analytics solutions in the life sciences and producer of the ...

2021-08-04 16:00 35644

OPEN Health acquires Spirit

LONDON, Aug. 4, 2021 /PRNewswire/ -- OPEN Health has today announced the acquisition of North West UK-based medical communications agency Spirit. Integrating the Spirit business with the OPEN Health Group further strengthens our ability to offer our global Medical Affairs audiences a broad range ...

2021-08-04 16:00 1371

NaviFUS begins FUS combined with radiotherapy clinical trial for the treatment of terminal primary brain tumors

TAIPEI, Aug. 4, 2021 /PRNewswire/ -- NaviFUS' focused ultrasound (FUS) therapy system (NaviFUS®) was recently approved for use in a new clinical trial by the Taiwan Food and Drug Administration (TFDA). It will be initiated shortly at Linkou Chang Gung Memorial Hospital. The trial will investigate...

2021-08-04 11:50 1536

TIENS Group will Become a Global Participant in the Future Massive Health Industry

TIANJIN, China, Aug. 4, 2021 /PRNewswire/ -- As announced proudly by TIENS Group's Chairman Li Jinyuan in theHealth Industry Development Forum of the Belt and Road in the Post-pandemic Era held in Tianjin, China, TIENS Group is poised to become one of main global participants in the future massiv...

2021-08-04 00:40 2241

Lumosa Therapeutics Announces Positive Results from LT3001 Phase 2a Clinical Trial in Acute Ischemic Stroke

* LT3001 met primary safety endpoint. No symptomatic intracranial hemorrhage occurred. * LT3001 showed pronounced neurological improvement in the majority of patients with baseline NIHSS≥6 treated with LT3001. * These data suggest that LT3001 has the potential to provide significant clinica...

2021-08-03 22:48 1554

Varigard Technologies Proven to Prevent the Tactile Spread of SARS-CoV-2, B.1.617.2 - DELTA Variant

Varigard's protective Hand Sanitizing lotion prevents the tactical spread of SARS-CoV-2, B.1.617.2 for two hours and for over 20 hours with its organic Surface Spray FOLEY, Ala., Aug. 3, 2021 /PRNewswire/ -- Varigard and Synergy Laboratories have announced the test results of an advanced hand sa...

2021-08-03 22:00 1503
1 ... 347348349350351352353 ... 573

Week's Top Stories